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ABSTRACT: We report the ﬁrst antimicrobial study of transparent and robust Cu-
doped ZnO coatings that displayed potent antimicrobial activity that resulted in
bacterial (Escherichia coli) reduction below detection limits within 6 h of
illumination via a white light source that is found in hospital environments. The
same bacterial reduction rate was observed even under darkness for 4.0 atom % Cu-
doped ZnO ﬁlms thus providing an eﬃcient 24 h disinfection. All ﬁlms were
produced via a novel, inexpensive, and easily scalable route and were also thoroughly
analyzed for their material properties.
■ INTRODUCTION
Nosocomial infections are a major concern for hospitals and
healthcare institutions globally.1−3 Many of these infections are
caused by multidrug-resistant strains of bacteria. If current
trends persist, by 2050 antimicrobial drug resistance would lead
to a loss of 10 million lives every year, with a reduction in the
world gross domestic product of 2−3.5%, which translates to a
cost of up to U.S. $100 trillion.4,5 In hospital environments,
which are the epicenter of a majority of these antimicrobial
drug-resistant infections, 80% of infections are due to
contaminated touch surfaces.6−8 Disinfection of such surfaces
is key to the ﬁght against spread of antimicrobial bacteria.
Antimicrobial surfaces and coatings are widely used and
usually consist of metal, metal oxides, or polymers doped with
organic antibacterial compounds, such as methylene blue.9−11
These coatings, when applied to high-contact touch surfaces in
healthcare environments, are proving to be eﬀective in the ﬁght
against hospital-acquired infections.
Zinc oxide is an inexpensive semiconducting material
extensively used in the optoelectronic industry due to its
wide band gap (3.3 eV at room temperature) and high electrical
conductivity. Recently, it has found use as an antimicrobial
agent and has seen application in the lining of food packaging
to reduce spoilage.12 The mechanism for the activity is complex
and not fully understood, but it is thought to be through
various paths, including the uptake of Zn2+ ions (released into
the surrounding environment from the metal oxide surface)
into cells. Zn2+ is an essential ion for many microorganisms due
to its involvement in various cellular reactions, but at
concentrations above 10−7 mol L−1 it becomes cytotoxic.13−16
Another process is that it induces the formation of powerful
oxidizing agents (such as hydrogen peroxide) within bacteria
cells that can cause cell damage.12 Further still, another action
of antimicrobial activity of ZnO arises from its photosensitive
properties. Upon irradiation by UV light with energy above 3.3
eV (sunlight and ﬂuorescent light sources commonly found
indoors emit light ca. 4% in the UV wavelengths, and some of
this UV light will have energy above 3.3 eV), ZnO oxidizes and
reduces water and oxygen (respectively) to produce reactive
oxygen species (ROS).12,17 These species can then cause
damage to an organism’s cell membrane, DNA, and protein
through Fenton type reactions, which result in cell death.18−23
Some believe this oxidative stress to be the primary mode of
antibacterial activity of most bactericidal metal oxides.24−27
Copper, a well-known antimicrobial agent, is thought to
show action against bacterium via Fenton type reactions.28−32
Although a powerful and eﬀective antimicrobial agent, copper is
expensive and so can have high costs when required to coat
high-contact surfaces that often have large areas. Furthermore,
unlike ZnO that is transparent, in the thin-ﬁlm form, Cu, Cu2O,
and CuO are not transparent but either opaque or colored.
This can lead to esthetic issues when it comes to real world,
nonlaboratory applications.
However, the use of copper as a dopant in a ZnO matrix may
potentially circumvent the two aforementioned issues while
enhancing the antimicrobial properties of ZnO. The use of Cu-
doped ZnO would allow the ﬁlms to remain transparent in the
visible spectrum and provide a cheap (as only a small quantity
of Cu is used) and mechanically robust solution while allowing
attack of the bacterium using both Cu and Zn.
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In this article, we report for the ﬁrst time, the antimicrobial
activity of Cu-doped ZnO thin ﬁlms. Although Cu-doped ZnO
thin ﬁlms have been reported before, their functional testing
has been limited to applications, such as photocatalysis,
ferromagnetics, and optoelectronics. To the best of our
knowledge, no previous papers have examined the antimicrobial
properties of Cu-doped ZnO in the thin-ﬁlm form. Cu-doped
ZnO has been investigated as an antimicrobial agent in the
nanoparticulate and bulk powder variant against both Gram-
negative and Gram-positive bacteria.33 Although nanoparticu-
late ZnOs (and metals/metal oxides in general) show superior
activity against bacteria compared with bulk powders or thin
ﬁlms due to the larger surface area (and hence higher contact
with the bacteria), they are diﬃcult to handle in nonlaboratory
situations when not immobilized. When immobilized in, for
example, polymers, they evidently lose some of their active
surface area and thus their eﬃciency advantage. Thin ﬁlms of
ZnO are easy to handle and hard wearing, with almost no
hazards to human health that are associated with loose
nanoparticles.
Also, in this article, we show the novel use of aerosol-assisted
chemical vapor deposition (AACVD) for the synthesis of the
Cu-doped ﬁlms. AACVD is a simple solution-based atmos-
pheric pressure ﬁlm growth technique that allows for easy scale
up. In AACVD, the precursors need not be volatile, as they are
simply dissolved in a suitable solvent and transferred to the
deposition chamber as an aerosol mist via a carrier gas (see the
Supporting Information).34,35 Films produced via AACVD are
of high quality and have been used in many applications.36−39
The pure and Cu-doped ﬁlms produced were tested for their
material properties and tested against Escherichia coli for their
antimicrobial functionality under both illuminated and dark
conditions. The results showed potent antibacterial activity
under both conditions.
■ RESULTS AND DISCUSSION
Pure and Cu-doped thin ﬁlms of ZnO were deposited on glass
substrates from methanol solutions of Zn(OAc)2·2H2O and
diﬀering molar concentrations of Cu(OAc)2·H2O at 350 °C
using AACVD on glass substrates. The ﬁlms were highly
transparent in the visible region with a slight green coloration
only at high (4.0 atom %) Cu dopant concentrations (see the
Supporting Information). The ﬁlms were also well adhered to
the substrate, passing the Scotch tape and scratch tests
involving pencils of various hardness.40 Films were also stable
when exposed to solvents such as methanol, toluene, and water.
Only weak acid was able to remove the coatings from the
substrates.
Material Characterization. Powder X-ray diﬀraction
(PXRD) showed the ﬁlms to be phase pure ZnO in the
Wurtzite crystal structure (Figure 1a). Peaks at 31.9, 34.8, 36.7,
48.0, 57.2, and 63.5° 2θ values corresponding to (100), (002),
(101), (102), (110), and (103) reﬂections, respectively, were
observed. The broad nature of the peaks suggests the ﬁlms have
poor crystallinity, primarily due to the relatively low deposition
temperature. Interestingly, the 4% Cu-doped sample was
relatively higher in crystallinity as evident from the narrower
nature of the peaks. Furthermore, for this ﬁlm, the peak
positions were shifted to higher 2θ values, indicating a possible
contraction of the ZnO unit cell.
UV−vis measurements were carried out on the pure and Cu-
doped ZnO ﬁlms to obtain transmittance and reﬂectance data
(Figure 1b). All ﬁlms had a high transmittance in the visible and
near-IR region with a sharp absorption edge in the UV. With
increasing Cu concentration, there was a decrease in trans-
mittance. At 4.0 atom % Cu loading, the ﬁlms showed a broad
absorption peak at ca. 590 nm, leading to a green ﬁlm.
The optical band gap was calculated for all ﬁlms by applying
the Tauc method to the UV−vis data, which showed no
signiﬁcant change in the band gap (3.3 eV) at the Cu doping
levels carried out in this study. The reduction of the ZnO band
gap when doping has only been achieved at high doping
concentrations in the literature.33 This is what was observed in
this study too (data not shown); however, at these
concentrations the ﬁlms have a dark green/black coloration,
which is not ideal esthetically as coatings on, for example, door
handles and keyboards for antimicrobial applications.
The microstructure of the ﬁlms was studied using a scanning
electron microscope (SEM) (Figure 2). The pure ZnO ﬁlm
appears to have a faceted microstructure not unlike previously
deposited ZnO ﬁlms via AACVD.41,42 Upon doping, especially
at the higher Cu concentration regime, 3.2 and 4.0 atom % Cu,
the morphology changes to a more globular structure consisting
of semicircular domes. The size of these domes, in general,
increases with increasing Cu concentration. For the 1.1 atom %
Cu/ZnO ﬁlm, the diameter of the domes was between a range
of 50 and 100 nm, whereas for the 3.2 and 4.0 atom % ﬁlms, the
Figure 1. (a) PXRD and (b) UV−vis spectra of the AACVD-deposited
ZnO and Cu-doped ZnO ﬁlms on glass substrates.
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range was between 100 and 600 nm. Overall, the ﬁlms appear
very compact and uniform, with no cracks, voids, or pinholes.
The ﬁlms were also analyzed using energy dispersive X-ray
spectroscopy (EDS) to probe the elemental composition (see
the Supporting Information). It showed the pure and doped
ZnO ﬁlms to be free of any contaminants. The doped samples
showed an increase in Cu concentration with increasing
AACVD precursor concentration. Films made using 2, 4, and
8 mol % of Cu(OAc)2·H2O relative to Zn(OAc)2·2H2O
showed 1.1, 3.2, and 4.0 atom % Cu compared with Zn in the
ﬁlms, respectively.
X-ray photoelectron spectroscopy (XPS) was carried out on
the pure and Cu-doped ZnO ﬁlms to determine the oxidation
state and chemical composition at the surface (Figure 3). The
core-level Zn 2p spectra showed peaks at 1021.5 eV for the
2p3/2 transition matching Zn in the +2 oxidation state, as
expected and concurring with the literature examples (Figure
3a). The Cu 2p spectra showed a high signal to noise ratio due
to the low dopant concentration (Figure 3b), but there is a
single 2p3/2 peak at 933.0 eV suggesting the presence of Cu in
the 0 and/or +1 oxidation states. It is diﬃcult to diﬀerentiate
between these two oxidation states of Cu from the XPS 2p
transition alone due to heavy peak overlap.43,44 Because of the
lack of a satellite peak around 940 eV that is normally
associated with Cu2+, it can be concluded that there is none or
very little Cu2+ present on the ﬁlm surface. The ratio of Cu to
Zn at the surface of the ﬁlms, as observed from the XPS peak
area analysis, increases with increasing dopant concentration
and follows the trend that was seen from EDX results (a bulk
analysis technique).
Valence band XPS of the ﬁlms can be separated and
discussed into two distinct features (Figure 4c,d). First, the
peak at 10 eV can be assigned to the Zn 3d transition, whereas
the second part between 7.5 and 0 eV, consisting of a broad
hump that has some ﬁne structure (when magniﬁed), is
comprised of two peaks at 6.5 and 4 eV. The small peak at 6.5
eV is made up of Zn 4s and O 2p mixing contributions, and the
peak at 6.5 eV is made up of only O 2p contributions.45 The
position of the valence band maxima with respect to the Fermi
level, determined via a simple linear extrapolation of the leading
edge, is 2.5 eV for the 4.0 atom % Cu-doped ZnO ﬁlm.
Antimicrobial Testing. The antimicrobial activity of the
undoped and Cu-doped ZnO ﬁlms deposited on microscope
glass slides were determined using E. coli, a Gram-negative
bacterium that is commonly found in hospital environments
(Figure 4). Samples were cut into 1 × 1 cm2 sections and were
covered with 25 μL of bacterial suspension containing
approximately 105 cfu. For each experiment, a set of samples
were illuminated with a white light source (28 W), emitting an
average light intensity of 3750 lx, at a distance of 30 cm from
the sample. In all experiments, a control sample set was
maintained in parallel and was stored under dark conditions for
the same exposure times. The ﬂuorescent lamp used emits light
across the visible region of the spectrum, similar to those
commonly found in U.K. hospitals. After incubation for set
times, bacteria were recovered from the samples and the
number of viable bacteria remaining was determined. The
results demonstrate that the ﬁlms indeed have antimicrobial
activity against E. coli. Each bar represents the log10 of the mean
number of viable bacteria from the two experiments carried out
at diﬀerent occasions, and error bars represent the calculated
standard error.
After 3 h of exposure (Figure 4a), all of the ﬁlms had a higher
activity in the light (L+) rather than the dark (L−), except for
the 4.0 atom % Cu-doped ZnO ﬁlm that had the same
reduction in bacterial numbers for both conditions (1.3 log10).
After 6 h of exposure (Figure 4b), all Cu-doped ZnO ﬁlms have
signiﬁcant reduction (P < 0.01) in the number of viable bacteria
to below the limit of detection in the light. In darkness, there
was only a small reduction in the counts for both 1.1 and 3.2
atom % Cu-doped ﬁlms. After 18 h of exposure (Figure 4c), all
samples (apart from pure ZnO in darkness) were able to impart
Figure 2. SEM images for (a) pure ZnO and (b) 1.1, (c) 3.2, and (d) 4.0 atom % Cu-doped ﬁlms grown via AACVD at 350 °C.
ACS Omega Article
DOI: 10.1021/acsomega.7b00759
ACS Omega 2017, 2, 4556−4562
4558
a reduction in the number of viable bacteria to below the
detection limits (P < 0.01).
Figure 3. Typical core-level XPS spectra for the Cu-doped ZnO ﬁlms
grown via AACVD at 350 °C consisting of (a) Zn 2p transitions
composed of a 2p3/2 peak at 1021.5 eV corresponding to Zn in the +2
oxidation. (b) Cu 2p spectrum made up of a single symmetrical peak
at 933.0 eV in the 2p3/2 region matching Cu(0)/Cu(I). (c) Valence
band XPS spectrum with a magniﬁed inset (d) for the 0−7.5 eV region
for the 4.0 atom % Cu-doped ZnO sample.
Figure 4. Number of viable colony counts of E. coli after incubation on
pure and Cu-doped thin ﬁlms on microscope slides. The number of
viable colony counts were determined after (a) 3, (b) 6, and (c) 18 h.
L+ = illuminated and L− = not illuminated (in the dark). * Indicates
E. coli levels below detection limits. (d) Multitude of possible
mechanisms via which Cu-doped ZnO is able to disinfect
contaminated surfaces. The diﬀering mechanisms of attack that
destroy cell membranes, DNA, and proteins of the microbes make the
development of resistant strains virtually impossible.
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The increased antimicrobial activity of the Cu-doped ﬁlms
under illumination compared to no illumination is most likely
due to a multimechanistic mode of attack. As shown in Figure
4d, it is possible that the light-activated Cu-doped ZnO samples
were able to disinfect via three routes: (1) oxidative stress
caused by ROS that are produced via reactions between
photocatalytically generated electrons/holes and H2O/O2, (2)
the Zn2+, Cu, Cu1+, and Cu2+ ions released from the ﬁlms that
are cytotoxins to microbes above certain concentrations, and
(3) ROS species produced via Fenton type reactions that also
cause oxidative stress upon microbes. However, in darkness,
route 1 is not likely; therefore, only routes 2 and 3 could take
place.
Cu-doped samples performed better compared to pure ZnO
under both light and dark conditions. Under darkness, this is
due to the antimicrobial properties of Cu, but under light
conditions, we believe it is due to superior charge carrier
lifetimes. One of the mechanisms of action for ZnO, when
illuminated with UV radiation above 3.3 eV, is via oxidative
stress caused by ROS. These species are produced via redox
reactions involving electrons (excited to the conduction band)
and holes (remaining in the valence band) on the surface of the
ZnO ﬁlms. The lower the recombination rate the longer the
lifetimes of the electron−hole pairs and the higher the chance
that these electrons and holes migrate to the surface from the
bulk to undergo the redox reactions. In Cu-doped ZnO, the
dopant states within the band structure act as trap sites
reducing recombination.46,47 This is common in many metal-
doped metal oxide systems and has been experimentally
determined using transient absorption spectroscopy.46 Hence,
Cu-doped ZnO samples show increased antimicrobial activity
over that of pure ZnO samples under light conditions.
Water Contact Angle Measurements. Evidence that the
ﬁlms are photocatalytically active and route 1 (in Figure 4d) is
able to proceed under white light illumination over the time
period of the antibacterial testing was determined through
water contact angle measurements (Figure 5). Photoinduced
wettability in ZnO occurs due to its photosensitivity.48,49 It
takes place when ZnO is activated with light of energy above
3.3 eV, through the migration of photogenerated electrons and
holes from the bulk to the surface of the ﬁlms, similar to route 1
shown in Figure 4d. Some of these holes are thought to react
with lattice oxygen to generate oxygen vacancies that are sites
for hydroxyl adsorption, which increases surface hydrophilicity
and reduces the contact angle between the surface and any
water droplet.48,50
The pure and Cu-doped ﬁlms showed a decrease in the water
contact angle with increasing irradiation time. As shown is
Figure 5b, the greatest decrease was observed for 4.0 atom %,
followed by 3.2 atom %, 1.1 atom %, and pure ZnO. This
collaborates with what was seen in the antibacterial study and
the earlier mentioned idea that the presence of Cu in the ZnO
ﬁlms enhances electron and hole lifetimes thus increasing the
probability of them reaching the surface of the ﬁlms without
recombination.
■ CONCLUSIONS
We demonstrate the novel use of AACVD for the growth of
pure ZnO and Cu-doped ZnO thin ﬁlms. The ﬁlms were phase
pure crystalline matching the hexagonal unit cell of the wurtzite
crystal structure. XPS analysis showed Zn in the +2 oxidation
state, whereas Cu was in 0 and/or +1 state on the surface. UV−
vis spectroscopy shows no signiﬁcant decrease in the band gap
with increasing Cu concentration in the ZnO matrix, as
previously seen for this level of Cu doping. The increased
antibacterial activity of the Cu-doped ZnO ﬁlms compared to
that of the pure ZnO ﬁlms was due to the multiple mechanisms
of attack allowed through oxidative stress caused by ROS and
cytotoxicity caused by the release of Zn2+, Cu0, Cu1+, and Cu2+
ions. The multiroute to disinfection also avoids the possible risk
of bacterial resistance development, a major concern in world
health care at present.
■ EXPERIMENTAL SECTION
All chemicals used in this report were purchased from Sigma-
Aldrich Chemical Co. and used as received. Deposition was on
microscope slides or 150 × 45 × 45 mm3 SiO2 (50 nm)-coated
ﬂoat-glass (the SiO2 acts as a barrier layer preventing diﬀusion
of ions from within the glass into the deposition ﬁlm), which
has been supplied by Pilkington NSG. Prior to use, the glass
substrates were cleaned with water, 2-propanol, and acetone.
Deposition Procedure. Depositions were carried out
under N2 (BOC Ltd., 99.99% purity) ﬂow. Zinc acetate
dihydrate (Zn(OAc)2·2H2O) (99%), copper dihydrate (Cu-
(OAc)·2H2O) (99%), and methanol (99%) were purchased
from Sigma and used as received.
Zn(OAc)2·2H2O (2.28 mmol) was dissolved in MeOH (30
mL) in a glass bubbler. The resulting solution was stirred for 10
Figure 5. (a) Photographs of the change in water contact angle on the
surface of the pure and Cu-doped ZnO ﬁlms with white light
irradiation time and (b) the change in contact angle on the pure and
Cu-doped ﬁlms, as a function of irradiation time.
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min and then atomized using a piezoelectric device (Johnson
Matthey liquifog). For the Cu-doped ZnO ﬁlms, Cu(OAc)·
2H2O (2, 4, and 8 mol % relative to Zn(OAc)2·2H2O) was
dissolved in methanol (30 mL) in a separate glass bubbler,
stirred for 10 min and then atomized. The Zn precursor and Cu
precursor ﬂows were both kept at 0.5 L min−1, and the two
aerosol ﬂows were mixed at a Y junction and delivered into the
cold wall chemical vapor deposition reaction chamber, as
shown in the Supporting Information, using the N2 carrier gas.
The glass substrate (4 mm ﬂoat glass coated with a SiO2
barrier layer) temperature was 350 °C, and the deposition time
was 60 min. After the deposition, the bubblers were closed and
the substrates were cooled under a ﬂow of air. Only the pure
ZnO ﬁlm was cooled under a N2 ﬂow. The glass substrate was
allowed to cool with the graphite block to less than 100 °C
before it was removed. Coated substrates were handled and
stored in air.
Characterization. Powder X-ray diﬀraction (PXRD) was
carried out using a modiﬁed Bruker-Axs D8 diﬀractometer, with
parallel beam optics and a PSD LynxEye silicon strip detector.
Unmonochromated Cu Kα source operated at 40 kV with 30
mA emission current was used. The incident beam angle was
set at 0.5° and the 2θ range of 10−65° was measured with a
step size of 0.05° at 1 s/step.
JEOL JSM-6301F ﬁeld emission scanning electron micro-
scope (SEM) at an accelerating voltage of 5 keV was used for
SEM measurements.
Optical measurements were carried out using a PerkinElmer
Fourier transform Lambda 950 spectrometer over a wavelength
range of 300−2500 nm.
X-ray photoelectron spectroscopy (XPS) was performed
using a Thermo Scientiﬁc K-Alpha photoelectron spectrometer
using monochromatic Al Kα radiation. Higher resolution scans
were recorded for the principal peaks of Cu(2p), Zn(2p),
O(1s), and C(1s) at a pass energy of 50 eV. The peaks were
modeled using CasaXPS software, with binding energies
adjusted to adventitious carbon (284.5 eV) for charge
correction.
Antimicrobial Activity. A procedure similar to that of
Hassan et al. was used for the antibacterial tastings.28
Brain heart infusion (BHI) agar (Oxoid; Basingstoke, U.K.)
was used to maintain E. coli strain (ATCC 25922) by weekly
subculture. Ten milliliters of sterile BHI broth (Oxoid;
Basingstoke, U.K.) was inoculated by E. coli and incubated
aerobically with shaking at 37 °C for 24 h. Bacteria from the
overnight culture were collected by centrifugation at 13 000g
for 1 min. E. coli was then resuspended in phosphate-buﬀered
saline (PBS) (Oxoid; Basingstoke, U.K.) and centrifuged at 13
000g for 1 min. The bacterial pellet was resuspended in PBS
prior to use. The cloudiness of the bacterial cell suspension was
measured at 600 nm using a spectrophotometer and was
adjusted to an optical density of approximately 105 cfu per 25
μL aliquot.
The pure ZnO and Cu-doped ZnO slides were cut into 1 × 1
cm2 sections. A humidity chamber was used to minimize drying
out of the suspensions. A 25 μL aliquot of the bacterial cell
suspension was spread on each slide and incubated at room
temperature (21 ± 2 °C) for the required exposure time. For
each exposure time (3, 6, and 18 h), triplicate samples were
analyzed and uncoated glass microscope slides were used as a
control. The samples were then irradiated for up to 18 h using a
white light source (General Electric 28 W Watt Miser T5 2D
compact ﬂuorescent lamp) emitting an average light intensity of
3750 lx at a distance of 30 cm from the samples. A further set of
samples (in triplicate) was maintained in the dark for the
duration of the irradiation time. Each exposure time was
repeated on two separate occasions
Postincubation, the slides were aseptically transferred to a
225 μL PBS and vortexed for 30 s to release the bacteria into
the solution. Serial dilutions of the resulting bacterial
suspensions were prepared in PBS and 25 μL from each
dilution was spread on to MacConkey agar (Oxoid;
Basingstoke, U.K.). Plates were incubated aerobically at 37
°C for 24 h. Postincubation, any bacterial colonies formed were
counted and the number of viable bacteria was calculated. The
Mann−Whitney U test was used to determine the signiﬁcance
of the activity of zinc oxide or copper zinc oxide slides
compared with the glass control.
Water Contact Angle Measurements. Water droplet
contact angles were measured using a First Ten Angstroms
1000 device, with a side-mounted rapid ﬁre camera ﬁre-casting
3 μL droplets from a ﬁxed height onto the surface.
Photoinduced wettability was tested by placing the samples
under a white light source for 0, 3, 6, and 18 h and then
measuring the water contact angle by placing a 3 μL droplet
onto the surface of the ﬁlms.
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